Diabetic Retinopathy
University of Utah researchers have found that activating a protein that stabilizes blood vessels reverses diabetic retinopathy and age-related macular degeneration - two common causes of blindness. They believe the treatment, which they tested in mice, may portend good news for many other diseases as well that occur or worsen because of vascular instability and leaky vessels.
Ref. https://deseretnews.com/article/1,5143,695262207,00.html
Gene therapy in a droplet could treat eye diseases, prevent blindness
Eye diseases such as diabetic retinopathy and age-related macular degeneration are among the leading causes of irreversible vision loss and blindness worldwide. Currently, gene therapy can be administered to treat these conditions -- but this requires an injection. Now researchers report a new way to deliver the treatment topically, without a needle. Ref. Source 2z.
New biomarkers predict accelerated diabetic eye disease. Young onset type 2 diabetes patients have an increased risk of developing diabetic retinopathy at an earlier stage and at a greater frequency, according to researchers. Ref. Source 6f.
Unexpected finding may deter disabling diabetic eye disease. A new study is the first to find that a particular type of lipid, or fat, thought to only exist in the skin, now lives in your eye and might play a major role in deterring diabetic retinopathy. Source 9u.